MLLStart! advised Clinical Research Ventures (CR Ventures), a Singapore, Frankfurt and Boston based global life-science investor with a focus on companies entering Phase I or II clinical trials in its investment into BioVersys AG, Basel, a biotech company focusing on research and development of small molecules which switch off drug resistance against antibiotics.
The investment forms part…